Mouse Anti-LGALS3BP Recombinant Antibody (CF268) (CBMAB-FT226LY)

Zhao, C., Liu, Y., Meng, J., Wang, X., Liu, X., Li, W., ... & Hou, S. (2022). Lgals3bp in Microglia Promotes Retinal Angiogenesis through Pi3k/Akt Pathway During Hypoxia. Investigative Ophthalmology & Visual Science, 63(8), 25-25.

Song, Y., Wang, M., Tong, H., Tan, Y., Hu, X., Wang, K., & Wan, X. (2021). Plasma exosomes from endometrial cancer patients contain LGALS3BP to promote endometrial cancer progression. Oncogene, 40(3), 633-646.

Kyrousi, C., O’neill, A. C., Brazovskaja, A., He, Z., Kielkowski, P., Coquand, L., ... & Cappello, S. (2021). Extracellular LGALS3BP regulates neural progenitor position and relates to human cortical complexity. Nature Communications, 12(1), 6298.

Luo, M., Zhang, Q., Hu, Y., Sun, C., Sheng, Y., & Deng, C. (2021). Lgals3bp: A potential plasma biomarker associated with diagnosis and prognosis in patients with sepsis. Infection and Drug Resistance, 2863-2871.

Cho, S. H., Shim, H. J., Park, M. R., Choi, J. N., Akanda, M. R., Hwang, J. E., ... & Chung, I. J. (2021). Lgals3bp suppresses colon inflammation and tumorigenesis through the downregulation of TAK1-NF-κB signaling. Cell death discovery, 7(1), 65.

Costa, J., Pronto-Laborinho, A., Pinto, S., Gromicho, M., Bonucci, S., Tranfield, E., ... & de Carvalho, M. (2020). Investigating LGALS3BP/90 K glycoprotein in the cerebrospinal fluid of patients with neurological diseases. Scientific reports, 10(1), 5649.

Kimura, R., Yoshimaru, T., Matsushita, Y., Matsuo, T., Ono, M., Park, J. H., ... & Katagiri, T. (2020). The GALNT6‑LGALS3BP axis promotes breast cancer cell growth. International Journal of Oncology, 56(2), 581-595.

Zhang, X., Ding, H., Lu, Z., Ding, L., Song, Y., Jing, Y., ... & Ni, Y. (2019). Increased LGALS3BP promotes proliferation and migration of oral squamous cell carcinoma via PI3K/AKT pathway. Cellular Signalling, 63, 109359.

Xu, G., Xia, Z., Deng, F., Liu, L., Wang, Q., Yu, Y., ... & Liu, S. (2019). Inducible LGALS3BP/90K activates antiviral innate immune responses by targeting TRAF6 and TRAF3 complex. PLoS pathogens, 15(8), e1008002.

Lodermeyer, V., Ssebyatika, G., Passos, V., Ponnurangam, A., Malassa, A., Ewald, E., ... & Goffinet, C. (2018). The antiviral activity of the cellular glycoprotein LGALS3BP/90K is species specific. Journal of virology, 92(14), 10-1128.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols

Related Products

Mouse Anti-LGALS3BP Recombinant Antibody (5 E3)

Mouse Anti-LGALS3BP Recombinant Antibody (CBYJL-1525)

Mouse Anti-LGALS3BP Recombinant Antibody (CBYCL-270)

Mouse Anti-LGALS3BP (AA 19-300) Recombinant Antibody (CBFYM-1215)

Mouse Anti-LGALS3BP Recombinant Antibody (SP-2)

Mouse Anti-LGALS3BP Recombinant Antibody (A896)

Mouse Anti-LGALS3BP Recombinant Antibody (1F8)

Mouse Anti-LGALS3BP Recombinant Antibody (A895)

Mouse Anti-LGALS3BP Recombinant Antibody (6B7)

Mouse Anti-LGALS3BP Recombinant Antibody (3D6)

Isotype control